Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Antares Pharma Inc (NASDAQ:ATRS)

1.41
Delayed Data
As of Aug 26
 -0.04 / -2.76%
Today’s Change
0.67
Today|||52-Week Range
2.03
+16.53%
Year-to-Date

Today’s Trading

Previous close1.45
Today’s open1.45
Day’s range1.38 - 1.49
Volume1,371,161
Average volume (3 months)900,896
Market cap$218.6M
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+48.15%
Earnings growth (this year)-7.14%
Earnings growth (next 5 years)+54.50%
Revenue growth (last year)+72.28%
P/E ratioNM
Price/Sales3.88
Price/Book3.26

Competitors

 Today’s
change
Today’s
% change
ELOSSyneron Medical Ltd-0.06-0.92%
TCMDTactile Systems Tech...-0.03-0.22%
TNDMTandem Diabetes Care...+0.06+0.86%
UTMDUtah Medical Product...-0.85-1.31%
Data as of 4:00pm ET, 08/26/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$45.7M
Annual profit (last year)-$20.7M
Net profit margin-45.25%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Robert F. Apple
Chief Financial Officer &
Senior Vice President
James E. Fickenscher
Corporate headquarters
Ewing, New Jersey

Forecasts

Partner Offers

Search for Jobs